世界の片頭痛治療市場予測(~2025年)

• 英文タイトル:Global Migraine Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Global Migraine Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025「世界の片頭痛治療市場予測(~2025年)」(市場規模、市場予測)調査レポートです。• レポートコード:GIR201114544
• 出版社/出版日:GlobalInfoResearch / 2020年10月
• レポート形態:英文、PDF、144ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥448,920 (USD3,480)▷ お問い合わせ
  Multi User¥673,380 (USD5,220)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、片頭痛治療の世界市場を調査対象にし、片頭痛治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(特定抗片頭痛薬、急性療法、予防療法、その他)、用途別分析(病院、クリニック、家庭用、その他)、市場予測(2021年~2025年)情報などを整理しました。
・市場概要
・企業情報:Allergan、GlaxoSmithKline、Teva、Merck、Endo International、Pfizer、Abbott、Johnson & Johnson、Amgen、Impax、Kowa Pharmaceuticals America、Amirall、Bayer、Revance Therapeutics、Winston Pharmaceuticals、Ethypharm、Eli Lilly、OptiNose、AstraZeneca、Novartis International、RedHill Biopharma、Valeant Pharma、Eisai、Biohaven Pharma、Bausch Health、NeurAxon
・企業別売上、市場シェア
・片頭痛治療の地域別市場分析
・片頭痛治療の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・片頭痛治療のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・片頭痛治療のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・片頭痛治療の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・片頭痛治療の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・片頭痛治療の種類別市場規模2015-2020:特定抗片頭痛薬、急性療法、予防療法、その他
・片頭痛治療の用途別市場規模2015-2020:病院、クリニック、家庭用、その他
・片頭痛治療の世界市場予測2021-2025:地域別、種類別、用途別
・調査の結果・結論

Market Overview
The global Migraine Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Migraine Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Migraine Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Migraine Therapeutics market has been segmented into:
Specific Anti-migraine Drugs
Acute Therapies
Preventative Therapies
Other

By Application, Migraine Therapeutics has been segmented into:
Hospitals
Clinics
Household Use
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Migraine Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Migraine Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Migraine Therapeutics market.

The report offers in-depth assessment of the growth and other aspects of the Migraine Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Migraine Therapeutics Market Share Analysis
Migraine Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Migraine Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Migraine Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in Migraine Therapeutics are:
Allergan
GlaxoSmithKline
Teva
Merck
Endo International
Pfizer
Abbott
Johnson & Johnson
Amgen
Impax
Kowa Pharmaceuticals America
Amirall
Bayer
Revance Therapeutics
Winston Pharmaceuticals
Ethypharm
Eli Lilly
OptiNose
AstraZeneca
Novartis International
RedHill Biopharma
Valeant Pharma
Eisai
Biohaven Pharma
Bausch Health
NeurAxon

レポート目次

Table of Contents

1 Migraine Therapeutics Market Overview
1.1 Product Overview and Scope of Migraine Therapeutics
1.2 Classification of Migraine Therapeutics by Type
1.2.1 Global Migraine Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Migraine Therapeutics Revenue Market Share by Type in 2019
1.2.3 Specific Anti-migraine Drugs
1.2.4 Acute Therapies
1.2.5 Preventative Therapies
1.2.6 Other
1.3 Global Migraine Therapeutics Market by Application
1.3.1 Overview: Global Migraine Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Household Use
1.3.5 Others
1.4 Global Migraine Therapeutics Market by Regions
1.4.1 Global Migraine Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Migraine Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Migraine Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Migraine Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Migraine Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Migraine Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Migraine Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Allergan SWOT Analysis
2.1.4 Allergan Product and Services
2.1.5 Allergan Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GlaxoSmithKline SWOT Analysis
2.2.4 GlaxoSmithKline Product and Services
2.2.5 GlaxoSmithKline Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Teva SWOT Analysis
2.3.4 Teva Product and Services
2.3.5 Teva Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Endo International
2.5.1 Endo International Details
2.5.2 Endo International Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Endo International SWOT Analysis
2.5.4 Endo International Product and Services
2.5.5 Endo International Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Abbott
2.7.1 Abbott Details
2.7.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Abbott SWOT Analysis
2.7.4 Abbott Product and Services
2.7.5 Abbott Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Johnson & Johnson SWOT Analysis
2.8.4 Johnson & Johnson Product and Services
2.8.5 Johnson & Johnson Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Amgen SWOT Analysis
2.9.4 Amgen Product and Services
2.9.5 Amgen Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Impax
2.10.1 Impax Details
2.10.2 Impax Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Impax SWOT Analysis
2.10.4 Impax Product and Services
2.10.5 Impax Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Kowa Pharmaceuticals America
2.11.1 Kowa Pharmaceuticals America Details
2.11.2 Kowa Pharmaceuticals America Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Kowa Pharmaceuticals America SWOT Analysis
2.11.4 Kowa Pharmaceuticals America Product and Services
2.11.5 Kowa Pharmaceuticals America Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.12 Amirall
2.12.1 Amirall Details
2.12.2 Amirall Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Amirall SWOT Analysis
2.12.4 Amirall Product and Services
2.12.5 Amirall Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.13 Bayer
2.13.1 Bayer Details
2.13.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Bayer SWOT Analysis
2.13.4 Bayer Product and Services
2.13.5 Bayer Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.14 Revance Therapeutics
2.14.1 Revance Therapeutics Details
2.14.2 Revance Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Revance Therapeutics SWOT Analysis
2.14.4 Revance Therapeutics Product and Services
2.14.5 Revance Therapeutics Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.15 Winston Pharmaceuticals
2.15.1 Winston Pharmaceuticals Details
2.15.2 Winston Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Winston Pharmaceuticals SWOT Analysis
2.15.4 Winston Pharmaceuticals Product and Services
2.15.5 Winston Pharmaceuticals Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.16 Ethypharm
2.16.1 Ethypharm Details
2.16.2 Ethypharm Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Ethypharm SWOT Analysis
2.16.4 Ethypharm Product and Services
2.16.5 Ethypharm Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.17 Eli Lilly
2.17.1 Eli Lilly Details
2.17.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Eli Lilly SWOT Analysis
2.17.4 Eli Lilly Product and Services
2.17.5 Eli Lilly Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.18 OptiNose
2.18.1 OptiNose Details
2.18.2 OptiNose Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 OptiNose SWOT Analysis
2.18.4 OptiNose Product and Services
2.18.3 OptiNose Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.19 AstraZeneca
2.19.1 AstraZeneca Details
2.19.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 AstraZeneca SWOT Analysis
2.19.4 AstraZeneca Product and Services
2.19.5 AstraZeneca Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.20 Novartis International
2.20.1 Novartis International Details
2.20.2 Novartis International Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Novartis International SWOT Analysis
2.20.4 Novartis International Product and Services
2.20.5 Novartis International Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.21 RedHill Biopharma
2.21.1 RedHill Biopharma Details
2.21.2 RedHill Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 RedHill Biopharma SWOT Analysis
2.21.4 RedHill Biopharma Product and Services
2.21.5 RedHill Biopharma Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.22 Valeant Pharma
2.23 Eisai
2.24 Biohaven Pharma
2.25 Bausch Health
2.26 NeurAxon
3 Market Competition, by Players
3.1 Global Migraine Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Migraine Therapeutics Players Market Share
3.2.2 Top 10 Migraine Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Migraine Therapeutics Revenue and Market Share by Regions
4.2 North America Migraine Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Migraine Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Migraine Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Migraine Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Migraine Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Migraine Therapeutics Revenue by Countries
5.1 North America Migraine Therapeutics Revenue by Countries (2015-2020)
5.2 USA Migraine Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Migraine Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Migraine Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Migraine Therapeutics Revenue by Countries
6.1 Europe Migraine Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Migraine Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Migraine Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Migraine Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Migraine Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Migraine Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Migraine Therapeutics Revenue by Countries
7.1 Asia-Pacific Migraine Therapeutics Revenue by Countries (2015-2020)
7.2 China Migraine Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Migraine Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Migraine Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Migraine Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Migraine Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Migraine Therapeutics Revenue by Countries
8.1 South America Migraine Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Migraine Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Migraine Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Migraine Therapeutics by Countries
9.1 Middle East & Africa Migraine Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Migraine Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Migraine Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Migraine Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Migraine Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Migraine Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Migraine Therapeutics Market Forecast by Type (2019-2024)
10.3 Specific Anti-migraine Drugs Revenue Growth Rate (2015-2025)
10.4 Acute Therapies Revenue Growth Rate (2015-2025)
10.5 Preventative Therapies Revenue Growth Rate (2015-2025)
10.6 Other Revenue Growth Rate (2015-2025)
11 Global Migraine Therapeutics Market Segment by Application
11.1 Global Migraine Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Migraine Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Household Use Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Migraine Therapeutics Market Size Forecast (2021-2025)
12.1 Global Migraine Therapeutics Market Size Forecast (2021-2025)
12.2 Global Migraine Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Migraine Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Migraine Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Migraine Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Migraine Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Migraine Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US




• 英文レポート名:Global Migraine Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025
• 日本語訳:世界の片頭痛治療市場予測(~2025年)
• レポートコード:GIR201114544お問い合わせ(見積依頼・ご注文・質問)